CuriosityStream to Report Third Quarter 2026 Financial Results on November 11
ACCESS Newswire (Tue, 13-Oct 9:00 AM ET)
Curiosity Stream Launches on Prime Video in Canada
ACCESS Newswire (Wed, 30-Sep 9:00 AM ET)
CuriosityStream Appoints Veteran Media Finance Executive Sean Piche as Chief Financial Officer
ACCESS Newswire (Wed, 26-Aug 4:15 PM ET)
Record Net Income Propels CuriosityStream to Raise Full-Year Outlook Amid Surging Licensing Revenue
Market Chameleon (Thu, 13-Aug 5:56 AM ET)
ACCESS Newswire (Wed, 12-Aug 4:05 PM ET)
Market Chameleon (Thu, 13-Nov 4:55 AM ET)
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The firm's products and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, and Others. The majority of the revenue comes from the direct business and Content licensing. Geographically, the company generates the majority of its revenue from the United States.
Curiositystream - Class A trades on the NASDAQ stock market under the symbol CURI.
As of October 13, 2026, CURI stock price climbed to $2.81 with 149,482 million shares trading.
CURI has a beta of 1.84, meaning it tends to be more sensitive to market movements. CURI has a correlation of 0.13 to the broad based SPY ETF.
CURI has a market cap of $166.60 million. This is considered a Micro Cap stock.
Last quarter Curiositystream - Class A reported $23 million in Revenue and $.15 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.12.
In the last 3 years, CURI traded as high as $7.15 and as low as $.45.
The top ETF exchange traded funds that CURI belongs to (by Net Assets): VTI, IWM, VXF, IWO, DES.
CURI has underperformed the market in the last year with a price return of -33.5% while the SPY ETF gained +20.2%. However, in the short term, CURI had mixed performance relative to the market. It has outperformed in the last 3 months, returning +8.4% vs +3.2% return in SPY. But in the last 2 weeks, CURI shares have been beat by the market, returning -3.1% compared to an SPY return of +1.6%.
CURI support price is $2.72 and resistance is $2.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CURI shares will trade within this expected range on the day.
